Showing 1,526 results

Filters Content type: News, Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Access to healthcare

Pharma refuses to ensure access to lifesaving hepatitis C treatment at global meeting

Editor's pick
Treatment Action Group
28 February 2014
Access to healthcare

Fighting For Global Access to Hepatitis C Therapies

Editor's pick
HepMag
19 February 2014
Hepatitis C treatment

Treating HCV -- Is the Price Right?

Editor's pick
Med Page Today
19 February 2014
Pharmaceutical industry

HIV/AIDS firms top new pharma reputation list

Editor's pick
PharmaTimes
14 February 2014
New & experimental hepatitis C treatment

Gilead's CEO Says New Hepatitis C Drug Attracts Payers

Editor's pick
Bloomberg Businessweek
13 February 2014
Pharmaceutical industry

Follows on “Pharmagate” plot: South Africa activists picket Merck office, while two drug companies leave pharmaceutical association

Editor's pick
Science Speaks
11 February 2014
New & experimental hepatitis C treatment

Gilead Files for U.S. Approval of Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Genotype 1 Hepatitis C

Editor's pick
Gilead press release
11 February 2014
New & experimental hepatitis C treatment

New hepatitis C pill lifts Gilead's 4Q sales

Editor's pick
Bloomberg Businessweek
7 February 2014
New & experimental hepatitis C treatment

Gilead to license hepatitis C drug to lower-cost manufacturers in India

Editor's pick
Reuters
6 February 2014
New & experimental HIV treatments

UK: Once-daily HIV pill Tivicay from ViiV gets launch

Editor's pick
Pharma Times
5 February 2014
New & experimental hepatitis C treatment

Abbvie Strong Hep C Drug Data and the Looming Battle With Gilead Sciences

Editor's pick
The Street
3 February 2014
Access to healthcare

At $84000 Gilead Hepatitis C Drug Sets Off Payer Revolt

Editor's pick
Bloomberg
27 January 2014
New & experimental hepatitis C treatment

Only just the beginning of the end of hepatitis C

Editor's pick
The Lancet (editorial)
26 January 2014
Pharmaceutical industry

Janssen Announces New Group Targeting Unmet Global Health Needs

Editor's pick
Janssen press release
22 January 2014
Pharmaceutical industry

Abbott Spinoff Faces New Trial on AIDS Drug Over Gay Juror Exclusion

Editor's pick
Bloomberg
22 January 2014
Access to healthcare

South African pharma firms accused of planning to delay patents law reform

Editor's pick
The Guardian
17 January 2014
New & experimental hepatitis C treatment

What Is a Hepatitis C Drug Worth?

Editor's pick
Roll Call
14 January 2014
Access to healthcare

Global Fund tiered pricing plan for ARVs, other health commodities raises questions

Editor's pick
Science Speaks
11 January 2014
Pharmaceutical industry

Brazil govt "hindering market entry of new HIV drugs"

Editor's pick
Pharma Times
8 January 2014
Pharmaceutical industry

Gilead Sales Chief Retires Amidst Key Hep C Drug Launch, Massive Insider Selling

Editor's pick
The Street
7 January 2014
New & experimental HIV treatments

Vertex's VX-765 holds promise for HIV treatment

Editor's pick
Motley Fool
7 January 2014
New & experimental hepatitis C treatment

$1000 Pill For Hepatitis C Spurs Debate Over Drug Prices

Editor's pick
NPR (blog)
6 January 2014
Pharmaceutical industry

Lack of drug data 'extreme concern'

Editor's pick
BBC Health
3 January 2014
Hepatitis C treatment

Gilead Sciences, Inc. (GILD): Gilead Seeks To Expand Its Blockbuster Hepatitis Platforms In 2014

Editor's pick
Seeking Alpha
3 January 2014